Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers

Clinical trial NCT01340898 · COMPLETED

Trial details

NCT number: NCT01340898
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningococcal Infection

Start date: 2012-01-27
Primary completion: 2014-08-04
Enrollment: 753

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.